Indefinite Delivery Contract 36C24E20D0033
Award Date
9/30/20
Last Date to Order
9/29/25
Funding Federal Agency
Headquarters
Contracting Federal Agency
Veterans Integrated Service Network 4
Awardee
Akesogen, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded Tempus AI, Inc. (doing business as Tempus Labs Inc.) a $64,296,441 Indefinite Delivery Contract (IDC) to provide tumor normal matched genomic testing services. Under this IDC, the VA issues firm fixed price delivery orders to Tempus for specialized genomic profiling and analysis of veteran cancer patients' tumor and normal tissue samples. The purpose is to support the VA's precision oncology initiatives by informing personalized treatment...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, for genomic analysis services worth up to $86.5 million over the period of performance ending September 29, 2025. This single-award IDC was issued by the VA Headquarters and does not include any socioeconomic set-asides. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Infinity Biologix for genomic sequencing, DNA...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 4 (VISN 4) awarded a $175 million single award indefinite delivery vehicle (IDV) contract to Personalis, Inc. for whole genome sequencing services. The contract has a period of performance from September 30, 2022 through September 29, 2025. Personalis, Inc., a for-profit genomic sequencing services provider, will perform the whole genome sequencing work at various facilities across...
The Department of Veterans Affairs (VA) awarded an indefinite-delivery/indefinite-quantity (IDIQ) contract to Foundation Medicine, Inc., a foreign-owned for-profit organization, for genomic sequencing testing services. The potential contract value exceeds $111 million and does not utilize any set-aside designations. Under this IDIQ contract, Foundation Medicine has been awarded multiple firm fixed price delivery orders to provide a range of genomic sequencing, next-generation sequencing (NGS),...
The U.S. Department of Veterans Affairs (VA) awarded a $130.7 million Indefinite Delivery Contract (IDC) to Foundation Medicine, Inc., a leading provider of genomic profiling and molecular analysis services, for specialized tumor molecular profiling services. This single-award IDC, with a completion date of September 12, 2029, aims to provide the VA's National Precision Oncology Program with comprehensive genomic profiling for both solid and hematological malignancies. The contracted services...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a single-award Blanket Purchase Agreement (BPA) contract to Qiagen, LLC, a division of Qiagen N.V., to provide gene mutation analysis services focusing on the JAK2 gene. The total ceiling value of the BPA is $325,157.75 over a period of performance from March 2020 to March 2025. Under the BPA, the agency has awarded multiple fixed-price task orders to Qiagen, LLC to deliver genetic...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded several delivery order contracts to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, to provide genome reagents and sequencing-related products and services. The initial $3.5 million indefinite delivery contract, established in December 2020, aims to supply the VA's Veterans Integrated Service Network 2 with proprietary ThermoFisher genome reagents and related services through December...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded an indefinite-delivery, indefinite-quantity (IDIQ) service contract to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract, valued up to $249,000, is for preventive maintenance and repair services on an Agena Bioscience MassArray system and associated Chip Prep Module located at the Central Arkansas Veterans Healthcare System (CAVHS)....
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $16 million single-award indefinite delivery contract (IDC) to Clear Labs Inc., a for-profit manufacturer and genomic analysis company, to provide COVID-19 genomic sequencing services and associated products. The contract, awarded in October 2022, has a period of performance through September 2027, with potential extensions. Under this IDC, Clear Labs has received multiple firm-fixed-price delivery orders to deliver...
The Department of Veterans Affairs Veterans Health Administration has awarded a single-award Indefinite Delivery Contract (IDC) worth $1,140,000 to Broad Clinical Laboratories, LLC of Cambridge, Massachusetts. This IDC has a period of performance through February 6, 2029 and is designed to provide genetic testing services to VA medical facilities within Veterans Integrated Service Network 1, which covers northern New England. Under the initial $270,000 firm fixed price delivery order, Broad...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36C24E20D0033-36C24E22N0189 | Akesogen, Inc. | $13.0m | 9/30/22 | 9/29/23 | 9/16/24 | |
Delivery Order 36C24E20D0033-36C24E23N0238 | Akesogen, Inc. | $6.4m | 9/30/23 | 9/29/24 | 9/19/23 | |
Delivery Order 36C24E20D0033-36C24E24N0168 | Akesogen, Inc. | $4.0m | 7/22/24 | 7/21/25 | 9/10/24 | |
Delivery Order 36C24E20D0033-36C24E20N0173 | Akesogen, Inc. | $9.9m | 9/30/20 | 3/20/24 | 5/22/24 | |
Delivery Order 36C24E20D0033-36C24E21N0180 | Akesogen, Inc. | $10.5m | 9/30/21 | 9/29/22 | 9/16/24 |